How has been the historical performance of Sakar Healthcare?

Answer:The historical performance of Sakar Healthcare shows a consistent growth trajectory in net sales and profitability over the past five years. Breakdown: Sakar Healthcare's net sales have increased from 94.74 Cr in Mar'21 to 177.58 Cr in Mar'25, demonstrating a strong upward trend. Total operating income has followed a similar pattern, rising from 94.74 Cr in Mar'21 to 177.58 Cr in Mar'25. The company's total expenditure has also grown, reaching 127.90 Cr in Mar'25, up from 72.14 Cr in Mar'21, primarily driven by rising raw material costs and employee expenses. Operating profit (PBDIT) has improved significantly, from 22.60 Cr in Mar'21 to 49.68 Cr in Mar'25, indicating enhanced operational efficiency. Profit before tax has increased from 13.23 Cr in Mar'21 to 21.53 Cr in Mar'25, while profit after tax has risen from 10.68 Cr in Mar'21 to 17.50 Cr in Mar'25. The company's earnings per share (EPS) have also shown growth, climbing from 6.84 in Mar'21 to 7.97 in Mar'25. On the balance sheet, total assets have expanded from 115.04 Cr in Mar'20 to 415.26 Cr in Mar'25, reflecting robust growth in shareholder's funds and reserves. Overall, Sakar Healthcare has demonstrated a solid financial performance with increasing revenues, profits, and asset growth over the years.